NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC

Clinical trials for NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy offers hope for Hard-to-Treat gut tumors

Disease control Recruiting now

This study tests two drugs, cabozantinib and lanreotide, in people with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that have stopped responding to other treatments. The goal is to find the best dose and see if the combination can slow tumor growth. About 49 …

Matched conditions: NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC

Phase: PHASE1, PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control

Last updated May 17, 2026 08:53 UTC

NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC

Get alerted when new NEUROENDOCRINE TUMORS,GASTROENTEROPANCREATIC trials appear

New combo therapy offers hope for Hard-to-Treat gut tumors